Abstract
Long non-coding RNAs (lncRNAs) are defined as a class of nonprotein-coding transcripts greater than 200 nucleotides in length, which have diverse functions in development and diseases including hematopoiesis. Recent advances have revealed that lncRNAs regulate hematopoietic development at almost every stage, including differentiation of the myelocyte, lymphocyte, and erythrocyte. Abnormal regulation of the lncRNAs may block aspects of blood development, which can lead to different types of hematopoietic disorders. These findings highlight the role of lncRNAs as potential therapeutic tools in malignant hematopoiesis. In this review, we summarize recent progress in the study of functional lncRNAs associated with blood development, as well as dysregulated lncRNAs involved in diverse blood diseases by interacting with crucial susceptibility genes in different pathways. In addition, we discuss genome-wide studies on lncRNAs, which are helpful for genome screening and in-depth functional study of lncRNAs associated with blood development and disease.
Article PDF
Similar content being viewed by others
References
Lee J T. Epigenetic regulation by long noncoding RNAs. Science, 2012, 338: 1435–1439
Wapinski O, Chang H Y. Long noncoding RNAs and human disease. Trends Cell Biol, 2011, 21: 354–361
Hung T, Chang H Y. Long noncoding RNA in genome regulation: Prospects and mechanisms. RNA Biol, 2010, 7: 582–585
Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature, 2009, 458: 223–227
Tsai M C, Spitale R C, Chang H Y. Long intergenic noncoding RNAs: New links in cancer progression. Cancer Res, 2011, 71: 3–7
Spizzo R, Almeida M I, Colombatti A, et al. Long non-coding RNAs and cancer: A new frontier of translational research? Oncogene, 2012, 31: 4577–4587
Vasilatou D, Papageorgiou S, Pappa V, et al. The role of microRNAs in normal and malignant hematopoiesis. Eur J Haematol, 2010, 84: 1–16
Sun Y M, Lin K Y, Chen Y Q. Diverse functions of miR-125 family in different cell contexts. J Hematol Oncol, 2013, 6: 6
O’Connell R M, Baltimore D. microRNAs and hematopoietic cell development. Curr Top Dev Biol, 2012, 99: 145–174
Garzon R, Pichiorri F, Palumbo T, et al. microRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci USA, 2006, 103: 5078–5083
Wagner L A, Christensen C J, Dunn D M, et al. EGO, a novel, noncoding RNA gene, regulates eosinophil granule protein transcript expression. Blood, 2007, 109: 5191–5198
Zhang X, Lian Z, Padden C, et al. A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster. Blood, 2009, 113: 2526–2534
Aoki K, Harashima A, Sano M, et al. A thymus-specific noncoding RNA, Thy-ncR1, is a cytoplasmic riboregulator of MFAP4 mRNA in immature T-cell lines. BMC Mol Biol, 2010, 11: 99
Hu W, Yuan B, Flygare J, et al. Long noncoding RNA-mediated anti-apoptotic activity in murine erythroid terminal differentiation. Genes Dev, 2011, 25: 2573–2578
Han B W, Chen Y Q. Potential pathological and functional links between long noncoding RNAs and hematopoiesis. Science signaling, 2013, 6: re5
Yu W, Gius D, Onyango P, et al. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature, 2008, 451: 202–206
Yildirim E, Kirby J E, Brown D E, et al. Xist RNA is a potent suppressor of hematologic cancer in mice. Cell, 2013, 152: 727–742
Khoury H, Suarez-Saiz F, Wu S, et al. An upstream insulator regulates DLK1 imprinting in AML. Blood, 2010, 115: 2260–2263
Benetatos L, Hatzimichael E, Dasoula A, et al. CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes. Leuk Res, 2010, 34: 148–153
Poliseno L, Salmena L, Zhang J, et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature, 2010, 465: 1033–1038
Qi P, Du X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol, 2012, 26: 155–165
Guttman M, Donaghey J, Carey B W, et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature, 2011, 477: 295–300
Ortega J J, Madero L, Martin G, et al. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: A multicenter study by the pethema group. J Clin Oncol, 2005, 23: 7632–7640
Sharma S, Findlay G M, Bandukwala H S, et al. Dephosphorylation of the nuclear factor of activated t cells (NFAT) transcription factor is regulated by an RNA-protein scaffold complex. Proc Natl Acad Sci USA, 2011, 108: 11381–11386
Collier S P, Collins P L, Williams C L, et al. Cutting edge: Influence of Tmevpg1, a long intergenic noncoding RNA, on the expression of Ifng by Th1 cells. J Immunol, 2012, 189: 2084–2088
Gomez J A, Wapinski O L, Yang Y W, et al. The NEST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-gamma locus. Cell, 2013, 152: 743–754
Eis P S, Tam W, Sun L, et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA, 2005, 102: 3627–3632
Elton T S, Selemon H, Elton S M, et al. Regulation of the miR155 host gene in physiological and pathological processes. Gene, 2012, doi: 10.1016/j.gene.2012.12.009
Cai X, Cullen B R. The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA, 2007, 13: 313–316
Beck-Engeser G B, Lum A M, Huppi K, et al. Pvt1-encoded microRNAs in oncogenesis. Retrovirology, 2008, 5: 4
Wang K C, Chang H Y. Molecular mechanisms of long noncoding RNAs. Mol Cell, 2011, 43: 904–914
Gupta R A, Shah N, Wang K C, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature, 2010, 464: 1071–1076
Kotake Y, Nakagawa T, Kitagawa K, et al. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15 (INK4B) tumor suppressor gene. Oncogene, 2011, 30: 1956–1962
Yap K L, Li S, Munoz-Cabello A M, et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4A. Mol Cell, 2010, 38: 662–674
Alharbi R A, Pettengell R, Pandha H S, et al. The role of HOX genes in normal hematopoiesis and acute leukemia. Leukemia, 2012, 27: 1000–1008
Calin G A, Sevignani C, Dumitru C D, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA, 2004, 101: 2999–3004
Sasaki Y T, Sano M, Kin T, et al. Coordinated expression of ncRNAs and HOX mRNAs in the human HOXA locus. Biochem Biophys Res Commun, 2007, 357: 724–730
Maamar H, Cabili M N, Rinn J, et al. Linc-HOXA1 is a noncoding RNA that represses Hoxa1 transcription in cis. Genes Dev, 2013, 27: 1260–1271
Wang K C, Yang Y W, Liu B, et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature, 2011, 472: 120–124
Bertani S, Sauer S, Bolotin E, et al. The noncoding RNA Mistral activates hoxa6 and hoxa7 expression and stem cell differentiation by recruiting MLL1 to chromatin. Mol Cell, 2011, 43: 1040–1046
Rinn J L, Kertesz M, Wang J K, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell, 2007, 129: 1311–1323
Lu L, Zhu G, Zhang C, et al. Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer. Breast Cancer Res Treat, 2012, 136: 875–883
Ishibashi M, Kogo R, Shibata K, et al. Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma. Oncol Rep, 2013, 29: 946–950
Geng Y J, Xie S L, Li Q, et al. Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J Int Med Res, 2011, 39: 2119–2128
Kogo R, Shimamura T, Mimori K, et al. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res, 2011, 71: 6320–6326
Zhuang Y, Wang X, Nguyen H T, et al. Induction of long intergenic non-coding RNA HOTAIR in lung cancer cells by type I collagen. J Hematol Oncol, 2013, 6: 35
Tsai M C, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science, 2010, 329: 689–693
Bonn B R, Krieger D, Burkhardt B. Cell cycle regulatory molecular profiles of pediatric T-cell lymphoblastic leukemia and lymphoma. Leuk Lymphoma, 2012, 53: 557–568
Geyer C R. Strategies to re-express epigenetically silenced p15 (INK4B) and p21 (WAF1) genes in acute myeloid leukemia. Epigenetics, 2010, 5: 696–703
Renner K, Ausserlechner M J, Kofler R. A conceptual view on glucocorticoid-induced apoptosis, cell cycle arrest and glucocorticoid resistance in lymphoblastic leukemia. Curr Mol Med, 2003, 3: 707–717
Drexler H G. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia, 1998, 12: 845–859
Tsihlias J, Kapusta L, Slingerland J. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Annu Rev Med, 1999, 50: 401–423
Williams R T, Sherr C J. The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias. Cold Spring Harb Symp Quant Biol, 2008, 73: 461–467
Iacobucci I, Sazzini M, Garagnani P, et al. A polymorphism in the chromosome 9p21 ANRIL locus is associated to Philadelphia positive acute lymphoblastic leukemia. Leuk Res, 2011, 35: 1052–1059
Tripathi V, Shen Z, Chakraborty A, et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet, 2013, 9: e1003368
Xu D, Yang F, Yuan J H, et al. Long noncoding RNAs associated with liver regeneration 1 accelerates hepatocyte proliferation during liver regeneration by activating Wnt/beta-Catenin signaling. Hepatology, 2013, 58: 739–751
Yang C, Li X, Wang Y, et al. Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells. Gene, 2012, 496: 8–16
Qin R, Chen Z, Ding Y, et al. Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis. Neoplasma, 2013, 60: 486–492
Alexandrova E M, Moll U M. Role of p53 family members p73 and p63 in human hematological malignancies. Leuk Lymphoma, 2012, 53: 2116–2129
Pant V, Quintas-Cardama A, Lozano G. The p53 pathway in hematopoiesis: Lessons from mouse models, implications for humans. Blood, 2012, 120: 5118–5127
Zhang X, Zhou Y, Mehta K R, et al. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab, 2003, 88: 5119–5126
Zhao J, Ohsumi T K, Kung J T, et al. Genome-wide identification of polycomb-associated RNAs by RIP-seq. Mol Cell, 2010, 40: 939–953
Zhang X, Gejman R, Mahta A, et al. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res, 2010, 70: 2350–2358
Hoffman B, Amanullah A, Shafarenko M, et al. The proto-oncogene c-Myc in hematopoietic development and leukemogenesis. Oncogene, 2002, 21: 3414–3421
Shtivelman E, Bishop J M. Effects of translocations on transcription from PVT. Mol Cell Biol, 1990, 10: 1835–1839
Carramusa L, Contino F, Ferro A, et al. The PVT-1 oncogene is a Myc protein target that is overexpressed in transformed cells. J Cell Physiol, 2007, 213: 511–518
Garding A, Bhattacharya N, Claus R, et al. Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the in cis downregulation of a gene cluster that targets NF-κB. PLoS Genet, 2013, 9: e1003373
Ratajczak M Z, Shin D M, Schneider G, et al. Parental imprinting regulates insulin-like growth factor signaling: A Rosetta Stone for understanding the biology of pluripotent stem cells, aging and cancerogenesis. Leukemia, 2013, 27: 773–779
Argiropoulos B, Palmqvist L, Imren S, et al. Meis1 disrupts the genomic imprint of Dlk1 in a NUP98-HOXD13 leukemia model. Leukemia, 2010, 24: 1788–1791
Ripoche M A, Kress C, Poirier F, et al. Deletion of the H19 transcription unit reveals the existence of a putative imprinting control element. Genes Dev, 1997, 11: 1596–1604
Gabory A, Ripoche M A, Le Digarcher A, et al. H19 acts as a trans regulator of the imprinted gene network controlling growth in mice. Development, 2009, 136: 3413–3421
Iizuka N, Oka M, Tamesa T, et al. Imbalance in expression levels of insulin-like growth factor 2 and H19 transcripts linked to progression of hepatocellular carcinoma. Anticancer Res, 2004, 24: 4085–4089
Esteves L I, Javaroni A C, Nishimoto I N, et al. DNA methylation in the CTCF-binding site I and the expression pattern of the H19 gene: Does positive expression predict poor prognosis in early stage head and neck carcinomas? Mol Carcinog, 2005, 44: 102–110
Ariel I, Miao H Q, Ji X R, et al. Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma. Mol Pathol, 1998, 51: 21–25
Bock O, Schlue J, Kreipe H. Reduced expression of H19 in bone marrow cells from chronic myeloproliferative disorders. Leukemia, 2003, 17: 815–816
Tessema M, Langer F, Bock O, et al. Down-regulation of the IGF-2/H19 locus during normal and malignant hematopoiesis is independent of the imprinting pattern. Int J Oncol, 2005, 26: 499–507
Takeuchi S, Hofmann W K, Tsukasaki K, et al. Loss of H19 imprinting in adult T-cell leukaemia/lymphoma. Br J Haematol, 2007, 137: 380–381
Runge S, Nielsen F C, Nielsen J, et al. H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein. J Biol Chem, 2000, 275: 29562–29569
Soares M R, Huber J, Rios A F, et al. Investigation of Igf2/Apai and H19/Rsai polymorphisms in patients with cutaneous melanoma. Growth Horm IGF Res, 2010, 20: 295–297
Ariel I, Sughayer M, Fellig Y, et al. The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma. Mol Pathol, 2000, 53: 320–323
Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression. Genome Res, 2012, 22: 1775–1789
Rinn J L, Chang H Y. Genome regulation by long noncoding RNAs. Annu Rev Biochem, 2012, 81: 145–166
Lee C S, Ungewickell A, Bhaduri A, et al. Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts. Blood, 2012, 120: 3288–3297
Brockdorff N. Noncoding RNA and polycomb recruitment. RNA, 2013, 19: 429–442
Landt S G, Marinov G K, Kundaje A, et al. ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res, 2012, 22: 1813–1831
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Wei, P., Han, B. & Chen, Y. Role of long non-coding RNAs in normal and malignant hematopoiesis. Sci. China Life Sci. 56, 867–875 (2013). https://doi.org/10.1007/s11427-013-4550-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-013-4550-9